2022

12/05/2022

Proteomics International awarded $400,000 to support manufacturing capability in Australia

 28/04/2022

Appendix 4C – March 2022 Quarterly Update

 12/04/2022

New Clinical Advisory Board for PromarkerD global rollout

 07/04/2022

Investor Presentation – Perth Healthcare Summit

 24/03/2022

PromarkerD patent granted in India

 10/03/2022

Investor Presentation

 24/02/2022

Appendix 4D and Interim Financial Report

 22/02/2022

PromarkerD completes ‘pre-assessment’ for Medicare rebate

 07/02/2022

Novel biomarkers identified for Asthma and COPD

 04/02/2022

Unique panel of biomarkers identified for oesophageal cancer

 28/01/2022

Appendix 4C – December 2021 Quarterly Update

Investors

ASX Announcements

2022 2021 2020 2019 2018 2017 2016 2015
Subscribe
  • This field is for validation purposes and should be left unchanged.
Menu